Patent Term Extension Application for LOQTORZI™ (toripalimab-tpzi), Patent No. 10,066,013

Documents

Comments

Key Dates

Comment Period OpensJan 26, 2024

Comment Period ClosesJul 30, 2025

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 20, 2026	--

CDER

Kilpatrick Townsend and Stockton LLP

Junmeng Biosciences Co., Ltd

Shanghai Junshi Biosciences Co., Ltd

Patent Term Extension Application

for LOQTORZI™ (toripalimab-tpzi)

Patent No. 10,066,013

OPEN